tradingkey.logo
tradingkey.logo
Pesquisar

Champions Oncology Inc

CSBR
Adicionar à lista de desejos
5.960USD
-0.085-1.41%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
82.77MValor de mercado
PerdaP/L TTM

Mais detalhes de Champions Oncology Inc Empresa

Champions Oncology, Inc. is a preclinical and clinical research services provider. The Company is engaged in the development and sale of advanced technology solutions and products to personalize the development and use of oncology drugs through its translational oncology solutions. This technology ranges from computational-based discovery platforms, oncology software solutions, and proprietary experimental tools such as in vivo, ex vivo and biomarker platforms. Utilizing its TumorGraft Technology Platform (the Platform), it provides select services to pharmaceutical and biotechnology companies seeking personalized approaches to drug development. It also sells Lumin Bioinformatics (Lumin), an oncology data-driven software program which contains comprehensive information derived from its research services and clinical studies. Lumin leverages a large data center coupled with analytics and artificial intelligence to provide a robust tool for computational cancer research.

Informações de Champions Oncology Inc

Código da empresaCSBR
Nome da EmpresaChampions Oncology Inc
Data de listagemNov 30, 1988
CEOBrainin (Robert)
Número de funcionários213
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 30
EndereçoOne University Plaza,
CidadeHACKENSACK
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal07601
Telefone12018088400
Sitehttps://championsoncology.com
Código da empresaCSBR
Data de listagemNov 30, 1988
CEOBrainin (Robert)

Executivos da empresa Champions Oncology Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Philip Breitfeld, M.D.
Dr. Philip Breitfeld, M.D.
Independent Director
Independent Director
--
--
Mr. Robert (Rob) Brainin
Mr. Robert (Rob) Brainin
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joel Ackerman
Mr. Joel Ackerman
Independent Director
Independent Director
1.06M
+8.94%
Dr. Ronnie Morris, M.D.
Dr. Ronnie Morris, M.D.
Chairman of the Board
Chairman of the Board
858.88K
--
Dr. David Sidransky, M.D.
Dr. David Sidransky, M.D.
Independent Director
Independent Director
767.04K
--
Mr. Scott R. Tobin
Mr. Scott R. Tobin
Independent Director
Independent Director
53.40K
+43.82%
Mr. Daniel N. (Dan) Mendelson
Mr. Daniel N. (Dan) Mendelson
Independent Director
Independent Director
--
--
Mr. David Miller, CPA
Mr. David Miller, CPA
Chief Financial Officer
Chief Financial Officer
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de Champions Oncology Inc?

Os cinco principais acionistas de Champions Oncology Inc são: Mr. Joel Ackerman

Quantas instituições possuem ações da Champions Oncology Inc (CSBR)?

Em 2026Q1, 61 instituições possuíam ações da Champions Oncology Inc, com valor de mercado aproximado de 6.66M, representando 47.97% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -413745.00.